Search for Q&As

Enquirers can use various factors to search for a Q&A:

  • These include searching by the Q&A ID; legal reference, date submitted, technical standard / guideline, or by keyword if known.
  • Searches can be extended to more than one legal act, topic, technical standard or guidelines by making multiple selections (i.e. pressing 'Ctrl' on your keyboard, and selecting the relevant ones from the drop-down lists by left mouse-click).

Disclaimer:

Q&As refer to the provisions in force on the day of their publication. The EBA does not systematically review published Q&As following the amendment of legislative acts. Users of the Q&A tool should therefore check the date of publication of the Q&A and whether the provisions referred to in the answer remain the same.

Please note that the Q&As related to the supervisory benchmarking exercises have been moved to the dedicated handbook page. You can submit Q&As on this topic here.

List of Q&A's

Z07.01.3 securities settlement services : content of number of clients

In the annex for IT solution of RESOL reporting Number of clients the following guidelines are given : Number of (resident and non-resident) clients to which the service is provided

  • Legal act: Directive 2014/59/EU (BRRD)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Z07.01.3 value of transactions for securities settlement services (function ID 3.4)

IN the Annex for IT solutions of the RESOL reporting for the function securities settlement the following guidance is given for the value of transactions : Value of securities transfers processed on behalf of clients. This includes transactions settled with a securities settlement system or settled internally by the reporting entities, and 'free-of-payment' transactions. Report only the value of transactions sent.  

  • Legal act: Directive 2014/59/EU (BRRD)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Application of the SME supporting factor to exposures financing private purposes following CRR III

Following the amendments introduced by Regulation (EU) 2024/1623 (CRR III), Article 501(2)(b) CRR defines an SME by reference to Article 5, point (9), CRR rather than to Commission Recommendation 2003/361/EC. Where the obligor is a natural person who carries out an economic activity and meets the turnover criterion in Article 5, point (9), should SME status be determined once at obligor level — so that the adjustment under Article 501(1) applies to all non-defaulted exposures to that obligor meeting Article 501(2)(a) — or should it continue to be assessed exposure by exposure by reference to the purpose of the individual financing, as set out in EBA Q&A 2021_6301?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

National competent authorities power to increase the quantity of ARTs and EMTS issuers' own funds or reserve assets in relation to Article 45(4)

Does Article 45(4) of Regulation (EU) 2023/1114 (MiCA) confer on national competent authorities or the EBA the power to require an ART or EMT issuer to increase the quantity of its own funds or reserve assets beyond the 1:1 backing established under Articles 36–38 of MiCA, or is the scope of Article 45(4) confined to requiring improvements to the composition, maturity and liquidity profile of reserve assets? More broadly, are the reserve and capital requirements that may be imposed on ART and EMT issuers under MiCA Level 1 capped by the mechanisms expressly provided for therein — in particular the bounded own-funds add-on mechanism of Article 35(5) following stress tests — such that national competent authorities or the EBA do not have discretion under Article 45(4) to impose open-ended or permanent structural overcollateralization or additional capital requirements beyond what MiCA Level 1 has expressly foreseen?

  • Legal act: Regulation (EU) No 2023/1114 (MiCAR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

F40.1 'Accumulated Equity interest' and 'Voting rights'

Template F40.1: For the purpose of reporting the institution’s “Accumulated equity interest [%]” and respectively the “Voting rights [%]” in an indirect subsidiary, is it correct to consider the indirect interest or the direct interest?  In other words, when Annex V refers to the percentage of ownership instruments and voting rights “held by the institution”, should this be assessed at the level of the reporting institution (ultimate parent undertaking) or at the level of the entity directly holding the interest in the subsidiary?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

EBA validation v7349_m

Is EBA validation v7349_m correct?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

C14.01 - EBA VR v7338_m

The EBA Validation Rule v7338_m applicable to the C14.01 template states that the exposure value deducted from own funds (c0420) should be equal or lower than the original exposure pre-conversion factors, split by tranches (c310, c320, c330, c340, c350, c360). Should this control be applicable?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

C14.00 - EBA VR v7349_m

The EBA Validation Rule v7349_m applicable to the C14.00 template states that the total exposure amount of the underlying assets at the reporting date (c0140) should be equal or lower than the sum of the on-balance sheet exposure amounts of the secutitisation's tranches (c0230, c0240, c0250).  Should this controls be applicable?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Template C 14.00 - Validation rule v7349_m_0 and the treatment of overcollateralisation reported in column c0254

Validation rule v7349_m_0 requires that: {C 14.00, c0140} ≤ {C 14.00, c0230} +{C 14.00, c0240} +{C 14.00, c0250} However, the validation rule does not take into account amounts reported in column c0254 (Overcollateralization and funded reserve accounts). At the same time, the reporting framework distinguishes overcollateralization and funded reserve accounts from the amounts reported in the senior, mezzanine and junior tranche columns. Furthermore, EBA Q&A 2023_6694 clarified that where an overcollateralization position meets the definition of a tranche it should be reported in the relevant tranche columns, whereas overcollateralization that does not meet the definition of a tranche should be reported in column c0254. In a securitization transaction where a portion of the credit enhancement is appropriately reported in column c0254 and does not constitute a tranche, the amount reported in column c0140 may exceed the sum of columns c0230, c0240 and c0250 solely because the amount reported in c0254 is excluded from validation rule v7349_m_0 which would result in the validation rule v7349_m_0 failing. Could the EBA clarify the intended application of validation rule v7349_m_0 in such cases? In particular: Should amounts reported in column c0254 be considered for the purposes of validation rule v7349_m_0, despite not being explicitly included in the formula? Alternatively, does the validation rule reflect the assumption that any overcollateralization relevant for this comparison should be reported within the tranche columns (c0230-c0250)? Where overcollateralization reported in c0254 does not meet the definition of a tranche, what is the expected reporting treatment considering in this instance that compliance with validation rule v7349_m_0 cannot be achieved?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) No 680/2014 - ITS on supervisory reporting of institutions (repealed)

The control formula v11889_m lacks sufficient evidential value.

Only the Total sheet  ([eba_qAE:qx2023]) must be empty for column 0070 (LGD).  Should control over another sheet (other than [eba_qAE:qx2023]) really exist ? Should it not be deleted ?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

The control formula v11888_m lacks sufficient evidential value.

Only the Total sheet  ([eba_qAE:qx2023]) must be empty for column 0050 (PD).  Should control over another sheet (other than [eba_qAE:qx2023]) really exist ? Should it not be deleted ?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

The control formula v10666_m lacks sufficient evidential value.

The control rule in place is incompatible with the EBA Filing Rules - section 2.18 on decimal precision requirements. Could these rules be amended?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

The control formula v10664_m lacks sufficient evidential value.

The control rule in place is incompatible with the EBA Filing Rules - section 2.18 on decimal precision requirements. Could these rules be amended?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

Annex II of Instructions for resolution planning report: Representation of Security Financial Transaction (SFT) under Netting Agreement not recognized for accounting and/or prudential purposes in Template Z16.00 and Z02.00

Could you please clarify how Securities Financing Transactions (SFTs) subject to a netting agreement that is not recognized for accounting and/or prudential purposes should be reported in Templates Z02.00.a (outstanding value) and Z16.00?

  • Legal act: Directive 2014/59/EU (BRRD)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2025/2303 - ITS on Resolution Planning Reporting

Validation Rule v22950_m – warning generated for exposure class [eba_qEC:qx2038] in C 07.00a

Validation rule v22950_m requires that cells in C 07.00a, row 0062 are blank for exposure class [eba_qEC:qx2038] – “Exposures secured by mortgages on immovable property and ADC”. However, the instructions for row 0062 state: “of which: IPRE exposures where the derogation set out in Article 125(2) of Regulation (EU) No 575/2013, second subparagraph is applied. Only reported in sub-exposure class ‘Secured by mortgages on residential immovable property – IPRE’.” According to the DPM hierarchy, qx2038 is the parent exposure class of – ‘Secured by mortgages on residential immovable property – IPRE’. As amounts reported are reflected in the corresponding parent exposure class, the inclusion of qx2038 in validation rule v22950_m generates a warning despite the reporting being consistent with the instructions.  Rule Reference: isnull ({tC_07.00.a, r0062, (c0010, c0030, c0040, c0150, c0160, c0165, c0170, c0175, c0180, c0190, c0195, c0200, c0215, c0220), default: null, interval: false} [ where qEBB in {[eba_qEC:qx16], [eba_qEC:qx23], [eba_qEC:qx22], [eba_qEC:qx21], [eba_qEC:qx20], [eba_qEC:qx19], [eba_qEC:qx2043], [eba_qEC:qx2036], [eba_qEC:qx2060], [eba_qEC:qx2037], [eba_qEC:qx2061], [eba_qEC:qx2063], [eba_qEC:qx2049], [eba_qEC:qx12], [eba_qEC:qx2050], [eba_qEC:qx13], [eba_qEC:qx18], [eba_qEC:qx14], [eba_qEC:qx1], [eba_qEC:qx25], [eba_qEC:qx26], [eba_qEC:qx2038], [eba_qEC:qx2039], [eba_qEC:qx2040], [eba_qEC:qx2041]}]) 

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

Consolidated application and intragroup transferability of the permanent exemption from deduction of equity holdings in an insurance company from CET1

For the purpose of defining the perimeter of application of the permanent exemption under Article 495a (3) CRR – whereby an institution, subject to the conditions specified therein, is permitted not to deduct from its own funds a shareholding held in an insurance undertaking – can such exemption, when applied by an institution on a standalone basis: extend also at consolidated level to the group of which such institution is a member? transfer, within the same group, to an institution to which the shareholding in the relevant insurance undertaking is assigned?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Maturity of a trading book position

For the purpose of calculating the Expected Shortfall under Article 325bd(4), can “the maturity of the trading book position” (parameter ‘Mat’) be interpreted to mean the time for which the exposure remains sensitive to the risks of the position currently held? For example: for a physical delivery derivative, it would be the maturity of the underlying. For others, it would depend on the capacity of replacing the position, which should typically be met for liquid listed derivatives.

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Not applicable

Validation rule EBA_v22949

Validation rule v22949 should be deactivated as it is not in line with reporting instructions.

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

CVA exemptions: marginal impact of reintegration

Annex II of the ITS requires to show the marginal impact of reintegration of CVA exemptions, separately for each exemption. it defines the marginal impact as "the difference, expressed in absolute amount, between the relevant metric for the scope of transactions referred to in row 0010 after reintegrating the exemption, and the relevant metric for the scope of transactions referred to in row 0010".  This statement may in our opinion be interpreted in two different ways: For each of the 7 exemptions and for the whole portfolio including the exemptions, institutions are required to calculate the cva risk charge for the non-exempted portfolio + the relevant exemption separately and report the difference to the cva risk charge calculated for the non-exempted portfolio. This requires 8 separate calculations and the marginal impact of individual exemptions will be accurate. However, the marginal impact for the individual exemptions will not add up to the marginal impact for the whole portfolio. Institutions are required to calculate the difference of the cva risk charge calculated for the whole portfolio to the cva risk charge calculated for the non-exempted portfolio. This difference will be split up for the 7 exemptions using the contributions on counterparty level already calculated for the whole portfolio. This requires 1 separate calculation and the marginal impact for individual exemptions will add up to the marginal impact for the whole portfolio. However, the marginal impact of each individual exemption will be only approximate (i.e. scaled by counterparty contributions). Question: are institution allowed to use method (2)?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2024/3117 - ITS on supervisory reporting of institutions

Classification of spread components of floating-rate instruments for contractual repricing reports

How should institutions classify the fixed spread component of a floating-rate instrument when reporting IRRBB repricing cash flows? Article 7 of Commission Implementing Regulation (EU) 2024/857 requires institutions to allocate the spread components of floating-rate instruments "up to the final contractual maturity, irrespective of any repricing of the non-amortised principal". However, Annex V, Section 3, states that the distinction between fixed-rate and floating-rate instruments is to be applied at instrument level. Under this definition, an instrument whose interest payments are contractually linked to an external benchmark is classified as a floating-rate instrument. In practice, two alternative interpretations have emerged: Cash-flow level interpretation: the fixed spread component of a floating-rate instrument is treated as a fixed-rate cash flow extending until contractual maturity and therefore reported within the fixed-rate section of the repricing templates. Instrument level interpretation: the spread component remains associated with the floating-rate instrument and is therefore reported within the floating-rate section, even though Article 7(c) requires the spread cash flows to be allocated up to final maturity. Should institutions report the spread components of floating-rate instruments in the fixed-rate section because they are allocated until final contractual maturity under Article 7(c), or should they remain in the floating-rate section because the fixed/floating classification applies at instrument level according to Annex V?

  • Legal act: Regulation (EU) No 575/2013 (CRR)
  • COM Delegated or Implementing Acts/RTS/ITS/GLs: Regulation (EU) 2016/2070 - ITS on Supervisory Reporting (for benchmarking the internal approaches) (as amended)